FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC

Although targeted therapy has improved the survival rates in the last decade, non-small-cell lung cancer (NSCLC) is still the most common cause of cancer-related death. The challenge of identifying new targets for further effective therapies still remains. The FAMily with sequence similarity 83 (FAM...

Descripción completa

Detalles Bibliográficos
Autores principales: Richtmann, Sarah, Wilkens, Dennis, Warth, Arne, Lasitschka, Felix, Winter, Hauke, Christopoulos, Petros, Herth, Felix J. F., Muley, Thomas, Meister, Michael, Schneider, Marc A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562954/
https://www.ncbi.nlm.nih.gov/pubmed/31083571
http://dx.doi.org/10.3390/cancers11050652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562954/
https://www.ncbi.nlm.nih.gov/pubmed/31083571
http://dx.doi.org/10.3390/cancers11050652

Ejemplares similares